Jakubík Jan, Randáková Alena, El-Fakahany Esam E, Dolezal Vladimír
Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
BMC Pharmacol. 2009 Dec 28;9:15. doi: 10.1186/1471-2210-9-15.
Many neuromuscular blockers act as negative allosteric modulators of muscarinic acetylcholine receptors by decreasing affinity and potency of acetylcholine. The neuromuscular blocker rapacuronium has been shown to have facilitatory effects at muscarinic receptors leading to bronchospasm. We examined the influence of rapacuronium on acetylcholine (ACh) binding to and activation of individual subtypes of muscarinic receptors expressed in Chinese hamster ovary cells to determine its receptor selectivity.
At equilibrium rapacuronium bound to all subtypes of muscarinic receptors with micromolar affinity (2.7-17 microM) and displayed negative cooperativity with both high- and low-affinity ACh binding states. Rapacuronium accelerated [3H]ACh association with and dissociation from odd-numbered receptor subtypes. With respect to [35S]GTPgammaS binding rapacuronium alone behaved as an inverse agonist at all subtypes. Rapacuronium concentration-dependently decreased the potency of ACh-induced [35S]GTPgammaS binding at M2 and M4 receptors. In contrast, 0.1 microM rapacuronium significantly increased ACh potency at M1, M3, and M5 receptors. Kinetic measurements at M3 receptors showed acceleration of the rate of ACh-induced [35S]GTPgammaS binding by rapacuronium.
Our data demonstrate a novel dichotomy in rapacuronium effects at odd-numbered muscarinic receptors. Rapacuronium accelerates the rate of ACh binding but decreases its affinity under equilibrium conditions. This results in potentiation of receptor activation at low concentrations of rapacuronium (1 microM) but not at high concentrations (10 microM). These observations highlight the relevance and necessity of performing physiological tests under non-equilibrium conditions in evaluating the functional effects of allosteric modulators at muscarinic receptors. They also provide molecular basis for potentiating M3 receptor-mediated bronchoconstriction.
许多神经肌肉阻滞剂通过降低乙酰胆碱的亲和力和效能,作为毒蕈碱型乙酰胆碱受体的负变构调节剂。已证明神经肌肉阻滞剂瑞帕库溴铵对毒蕈碱受体有促进作用,可导致支气管痉挛。我们研究了瑞帕库溴铵对乙酰胆碱(ACh)与中国仓鼠卵巢细胞中表达的各毒蕈碱受体亚型结合及激活的影响,以确定其受体选择性。
在平衡状态下,瑞帕库溴铵以微摩尔亲和力(2.7 - 17 microM)与所有毒蕈碱受体亚型结合,并与高亲和力和低亲和力ACh结合状态均表现出负协同性。瑞帕库溴铵加速了[3H]ACh与奇数编号受体亚型的结合和解离。关于[35S]GTPγS结合,单独的瑞帕库溴铵在所有亚型中均表现为反向激动剂。瑞帕库溴铵浓度依赖性地降低了ACh诱导的[35S]GTPγS结合在M2和M4受体处的效能。相反,0.1 microM瑞帕库溴铵显著增加了ACh在M1、M3和M5受体处的效能。在M3受体处的动力学测量显示,瑞帕库溴铵加速了ACh诱导的[35S]GTPγS结合速率。
我们的数据表明瑞帕库溴铵对奇数编号毒蕈碱受体的作用存在一种新的二分法。瑞帕库溴铵加速了ACh结合速率,但在平衡条件下降低了其亲和力。这导致在低浓度瑞帕库溴铵(1 microM)下受体激活增强,而在高浓度(10 microM)下则不然。这些观察结果突出了在非平衡条件下进行生理测试以评估变构调节剂对毒蕈碱受体功能影响的相关性和必要性。它们还为增强M3受体介导的支气管收缩提供了分子基础。